Zofran MDL Plaintiffs Say GSK’s Dismissal Motions Are Premature
(October 27, 2016, 1:16 PM EDT) -- BOSTON — Plaintiffs in the Zofran birth defect multidistrict litigation on Oct. 26 asked the court to strike defendant GlaxoSmithKline LLC’s (GSK) motion to dismiss certain cases on the issue of...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login